US Bancorp’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

US Bancorp’s Portfolio FURX Stock Details FURX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-531	Closed	-$56K	–	3670
2014 Q2	$56K	Buy	531 +16	+3%	+$1.57K	﹤0.01%	2427
2014 Q1	$45K	Hold	515	–	–	﹤0.01%	2529
2013 Q4	$22K	Hold	515	–	–	﹤0.01%	2748
2013 Q3	$23K	Sell	515 -270	-34%	-$11.2K	﹤0.01%	2634
2013 Q2	$27K	Buy	+785	New	+$27.6K	﹤0.01%	2549

US Bancorp's FURX Position: Q3 2014 in Review

US Bancorp sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 531 shares — an estimated $56K sold.

US Bancorp first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $56K in Q2 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

US Bancorp reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
US Bancorp sold 531 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $56K.
US Bancorp first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
US Bancorp's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $56K in Q2 2014.
0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on US Bancorp's 13F filing for Q3 2014, filed 14 Nov 2014.